GL1X · GenesisL1 explorer

Research workbench

Structure of human O-glcnac hydrolase with pugnac type inhibitor

Analyse Structure of human O-glcnac hydrolase with pugnac type inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5M7T
Type
protein
Length
898 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein O-glcnacase
EC
3.2.1.169, 3.2.1.-
UniProt
O60502
Ligands
GDV
Pockets
7 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein O-glcnacase (EC 3.2.1.169, 3.2.1.-)protein45149% helix, 9% strandO60502
BProtein O-glcnacase (EC 3.2.1.169, 3.2.1.-)protein44749% helix, 9% strandO60502

Ligands and binding sites

  • GDV · (5R,6R,7R,8S)-8-(acetylamino)-6,7-dihydroxy-5-(hydroxymethyl)-N-phenyl-1,5,6,7,8,8A-hexahydroimidazo[1,2-a]pyridine-2-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19780.830.8482empty
24760.680.7940GDV
34240.660.7941GDV
4920.580.8717empty
5670.350.7713empty

Interfaces

1 interface between chains.

  • A–B · 4380 Ų buried · 30 hydrogen bonds · protein-protein

Compared structures

  • 5M7T · Structure of human O-GlcNAc hydrolase with PugNAc type inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • O60502 · AlphaFold monomer V2.0 prediction for protein O-glcnacase (O60502) · a predicted model of the same protein · chain B against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.